Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2017

Derivative Instruments [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

		December 31, 2017		December 31, 2016
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	575,000	$	900,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars	$	-	$	57,000
Denominated in Canadian Dollars	$	36,000	$	54,000
Denominated in Pounds Sterling	£	-	£	48,000
Derivative instruments not designated:
Denominated in U.S. Dollars	$	408,007	$	-
Denominated in Canadian Dollars	$	80,000	$	37,000

Schedule of Derivative Instruments Included in Trading Activities [Table Text Block]

		Year Ended
	Location	December 31, 2017		December 31, 2016		December 31, 2015
Gain (loss) on forward exchange contracts recognized in income	Interest expense	$	(2,476)	$	8,544	$	14,474
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net	$	-	$	-	$	(58,427)
Gain on release of cumulative translation adjustment related to ineffectiveness on net investment hedge	Loss (gain) on derivatives, net	$	-	$	(2,516)	$	-
Gain (loss) on forward exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI	$	(252,168)	$	357,021	$	298,116
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis. In February 2015, Genesis closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.